Bariatric Surgery in Cirrhosis: A Clinical Practice Update From the AGA
The American Gastroenterological Association (AGA) has issued a clinical practice update regarding bariatric surgery in cirrhosis.
The American Gastroenterological Association (AGA) has issued a clinical practice update regarding bariatric surgery in cirrhosis.
Patients who undergo RYGB are less likely to need antihypertensive medications at 3 years compared with those who manage their blood pressure with medical therapy alone.
Results from a retrospective study found that obesity in men and younger patients with COVID-19 was associated with an increased risk for death.
Obesity is a strong, independent risk factor for poor outcomes among COVID-19 patients.
For postmenopausal women, antidepressants, beta-blockers, and insulin are associated with weight gain over three years.
Having increased body weight or abdominal obesity is associated with increased incidence of dementia.
For individuals in rural communities, extended care for obesity management via individual telephone counseling reduces weight regain.
The diet and physical activity guideline for the prevention of cancer has been updated by the American Cancer Society.
Even moderate weight loss before bariatric surgery significantly reduces the risk for mortality in the 30 days after the operation.
High body weight variability may be associated with increased risk for all-cause dementia and Alzheimer dementia in older patients.